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from 2 laboratories
CARDIOMYOCYTE 
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left ventricular rat heart tissue.(9) While the cells do not beat 
and differ morphologically from isolated adult cardiomyocytes, 
similarities with primary cardiomyocytes have been reported, 
specifically in terms of the presence and dynamics of L-type 
calcium channels, a similar cell membrane lectin binding pattern 
and comparable G-protein composition associated with ligand 
stimulated intracellular signalling.(10,11) As such, the H9c2 cell 
line has been used extensively in research to study the mecha-
nisms of cardiac hypertrophy,(12) oxidative stress,(13,14) ischaemia/
reperfusion (I/R),(15,16) and cardiotoxicity.(17) These cells, how-
ever, also have the capacity to adopt features of differentiated 
skeletal or cardiac muscle upon long term culture with low 
serum levels,(9,18) and in the case of cardiac specific differentiation, 
daily treatment with retinoic acid (RA).(19,20)
It has previously been reported that H9c2 cells maintained at 
confluency for an extended period of time (7 - 10 days), in the 
presence of relatively low concentrations of serum (1%), as well 
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The undifferentiated clonal cell line, H9c2, derived from 
left ventricular rat heart tissue, has been extensively 
used in cardiovascular research. In the present study, 
2 independent laboratories aimed to investigate the 
cells’ capacity to differentiate into distinct cardiac-like 
cells. Undifferentiated H9c2 cells were supplemented 
daily for a period of 6 - 12 days, with varying con-
centrations of retinoic acid (RA) (10nM, 30nM and 1μM), 
in standard cell culture medium containing either 1% 
foetal bovine, or horse serum, in order to stimulate 
differentiation of the cells into a more cardiac-specifi c 
phenotype. Light microscopy confi rmed some degree of 
morphological change associated with differentiation, 
and a signifi cant increase in oxidative phosphoryla-
tion following RA treatment was observed. However, 
Western blot probing for the cardiac-specifi c markers 
Cardiac Troponin T (cTnT) and Myosin Light Chain-2v 
(MLC2v) indicated little to no differentiation, although 
immunocytochemistry indicated the presence of cTnT 
expression. Thus, it was found that the differentiation 
protocol induced differentiation in some, but not all 
cells, thereby generating a heterogeneous cell popula-
tion. Our fi ndings suggest that the H9c2 cell line may 
display some degree of resistance to differentiation. This 
should be kept in mind when considering to use this 
model for cardiovascular research.  SAHeart 2017;14:96-107
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INTRODUCTION
The affliction of cardiovascular disease (CVD) is escalating 
rapidly throughout the world, with the majority of sufferers 
residing in developing countries.(1) According to the World 
Health Organisation (WHO), CVD is the leading cause of 
death globally accounting for an estimated 31% of all deaths 
worldwide.(2) Cardiovascular disease also poses a threat to the 
African continent, with several studies showing the prominence 
of a variety of cardiovascular afflictions in the African context, 
including heart failure and systolic dysfunction,(3) ischaemic 
heart disease (IHD),(4) hypertension and hypertensive heart 
disease(5) with associated heart failure.(6) Available data from 
the Medical Research Council of South Africa suggests that 
the predominance and treatment of common heart conditions 
in the population such as heart failure, cardiac hypertrophy and 
diseases of the valves and heart muscle are to a large extent, 
poorly managed.(7) Duly, it has become a crucial goal for 
researchers to develop and implement new and improved 
treatment strategies to protect the heart against disease and 
injury.
In previous research to date, a number of in vitro cell based 
models have been used to investigate heart physiology and 
pathology, with the advantage that cell models provide an 
ethically acceptable research tool, enabling the targeting of 
specific cellular processes with relative consistency and 
reproducibility.(8) In 1976, Kimes and Brandt established an 
undifferentiated clonal cell line, H9c2, derived from embryonic 
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as daily supplementation with RA, exhibit features indicative of 
cardiac specific differentiation.(19,20) These include an increased 
expression of cardiac specific proteins such as Myosin Light 
chain-2v (MLC-2v) and Cardiac Troponin T (cTnT),(19,20) as 
well as a shift in metabolic preference from primarily glycolytic 
to oxidative metabolism.(20) Lopashuk, et al. (2010) identified 
that a switch from glycolysis to oxidative phosphorylation is a 
fundamental characteristic of differentiated cardiac cells, since 
cardiomyotubes prefer fatty acids to glucose as a source of 
fuel.(21)
It could be argued that when differentiated, the H9c2 cells 
would offer a more closely matched representation of adult 
cardiomyocytes than when undifferentiated. Menard, et al. 
(1999) stated that the H9c2 cells are easy to manipulate, and 
when differentiated, provide a suitable cardiac cellular model 
with a maintained cardiac phenotype for a range of investiga-
tions commonly challenging to perform on primary cardio-
myocytes.(19) It is therefore tempting to pursue differentiation 
of these cells as a more relevant experimental model than 
the undifferentiated cardiomyoblast cell line. 
This paper will describe the efforts of 2 laboratories, working 
independently from one another, to differentiate H9c2 cells. 
Both laboratories are affiliated with the University of 
Stellenbosch  (South Africa). “Lab 1” is situated at the 
department of Physiological Sciences in the Faculty of Natural 
Sciences, while “Lab 2” is part of the division of Medical 
Physiology in the Faculty of Medicine and Health Sciences. 
Each laboratory independently investigated the capacity of the 
H9c2 cell line to differentiate into a more cardiac-specific cell 
line upon daily treatment with RA and/or reduced serum 
conditions as described by Pereira, et al. and Menard, et al. 
respectively.(19,20)
Lab 1 made use of bright field microscopy to investigate 
morphology, Western blotting to investigate the expression of 
the cardiac specific marker MLC-2v, and immunocytochemistry 
to assess the expression of a second cardiac specific marker, 
cTnT. Oxidative phosphorylation analysis was carried out to 
establish whether any changes in oxygen consumption had 
occurred following differentiation. Similarly, following daily RA 
treatment, Lab 2 attempted to confirm differentiation of the 
H9c2 cell line using Western blotting techniques to probe for 
the expression of the cardiac specific markers MLC and cTnT. 
Although it was hypothesised that H9c2 cells would easily 
differentiate to offer a good representation of cardiac physi-
ology, both laboratories generated data suggesting that the 
ability of these cells to fully differentiate is somewhat limited. 
This implies that the H9c2 cell line may not be as easy to 
manipulate as previously thought, and their use as a cardiac 
model in future research should be thoroughly assessed due to 
their apparent resistance to differentiation.
METHODS AND MATERIALS
Lab 1
Cell culture and general cell maintenance
An H9c2 (2-1) cell line, originally derived from embryonic left 
ventricular rat heart tissue through the method of selective 
serial passaging,(9) was purchased through Sigma Aldrich from 
the European Collection of Authenticated Cell Cultures 
(ECACC), Salisbury, UK. These cells were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) (Gibco, 41965-039) supple-
mented with 10% foetal bovine serum (FBS) (Biocom Biotech, 
FBS-G1-12A) and 1% penicillin/streptomycin solution (Thermo-
Fisher Scientific, 15140-122), at 37°C under 95% O2 and 5% 
CO2. H9c2 cells adhered well to the surface of culture dishes 
and no adhesion factor was necessary. Culture medium was 
refreshed every second day and the cells were maintained until 
they reached 70% confluency. Once confluent, culture medium 
was discarded and trypsin (Trypsin-EDTA, Gibco, 25200-012) 
was then used to lift the cells from the base of the culture plate. 
Cells were counted to determine the appropriate seeding 
densities for each experiment. Experiments were done on cells 
between passage 7 and 10.
Differentiation of H9c2 cells
H9c2 cardiomyoblast differentiation was induced according to 
a protocol described by Pereira, et al. (2011), in which serum 
was reduced to 1% and cells were supplemented daily with 
10nM of RA (Sigma, R2625) for 11 days.(20) For comparison, 
some cells were maintained in either 10% FBS (control), or in 
1% FBS for the same duration, but without RA. 
Morphological assessment
Morphological changes associated with differentiation of the 
treated cells were observed using bright field microscopy on 
days 6 and 11 of RA treatment. As described by Kimes and 
Brandt (1976), undifferentiated H9c2 cells appear typically 
spindle shaped and mononucleated.(9) Upon differentiation 
however, the cells have been reported to appear as long and 
thin branched cardiomyotubes.(20)
Immunocytochemistry
H9c2 cells were seeded onto coverslips and grown and treated 
as previously described. At the end of the treatment protocol, 
culture medium was removed, cells were washed with ice cold 
PBS and fixed in cold 4% paraformaldehyde (Sigma, 158127) 
for 10 mins. Cells were washed in cold PBS, blocked in 1% BSA, 
permeated with 0.1% triton solution (Sigma, X-100) and 
incubated at 4°C with cardiac specific troponin T (cTnT) 
antibody (Abcam, 11C11) overnight. The cells on the coverslip 
were again washed with cold PBS and incubated with an Alexa 
Fluor anti-mouse secondary antibody (ThermoFisher Scientific, 
A11029) for 1 hour in the dark. This was followed by staining 
with Hoechst (ThermoFisher Scientific, H1399), where after 
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the slide was left to air dry. Once dry, the coverslip was 
mounted on a glass slide using Dako fluorescent mounting 
medium (Diagnostech, S302380) and images were acquired 
using a Nikon eclipse E400 fluorescent microscope equipped 
with a DMX1200 CCD Camera 200. Images were acquired 
using the Nikon plan Flour 10x and 20x objective lens.
Preparation of cell extracts
Cell extracts were prepared as follows: lysis buffer (pH 7.4) 
containing: Tris–HCl (50mM), NP-40 (1%), Na-Deoxycholate 
(0.25%), EDTA (1mM), NaF (1mM), SBTI (4mg/ml), PMSF 
(1mM), Benzamidine (1mM), leupeptin (1mg/ml) and Triton 
X-100 (1ml) was added to the cells and the cell solution was 
then transferred to new tubes. Cells were sonicated, centrifuged 
(8 000rpm at 4°C for 10 mins), and the supernatant transferred 
to new tubes. Protein concentrations were determined with 
the Bradford method,(22) while others were diluted in Laemmli 
buffer and stored for Western blot analysis.
Western Blot analysis
Protein separation was performed on a 12% stain free, fast cast 
gel (Bio-rad, 161-0184) which was prepared according to the 
manufacturer’s instructions. The gel was run to completion at 
180mV and then activated on the Chemi Doc™ XRS system 
(Bio-rad). The proteins were then transferred onto nitrocellulose 
membranes (Bio-rad, 170-4156) for 10 mins at 25V and 1.3A. 
Following transfer, the membrane was blocked for 2 hours in 
Tris-buffered saline and Tween-20 (TBST, pH7.6) containing 
5% non-fat dry milk and incubated overnight at 4°C with the 
Myosin Light Chain (Cell Signaling, D5I1C) primary antibody 
solution. The membranes were incubated with the appropriate 
secondary antibody (Cell Signaling, 70745) at room temperature 
for 1 hour followed by washes with TBST. The Pierce ECL 
Western blotting substrate (Thermo Scientific, 32106) was 
used to detect protein bands using the ChemiDoc™ XRS+ 
System with Image Lab™ Software (Bio-Rad). The bands 
generated were expressed using the volume analysis tool and 
represented as a percentage (%) of the control sample. GAPDH 
(Cell Signaling, 1745) was used for the standardisation of 
protein loading.
Oxygraph analysis
The assessment of respiration rate is an ideal measure of the 
oxidative phosphorylation capacity in cells. The Hansatech 
oxygraph system was used to determine respiration rate in 
differentiated cells. Assessment was only performed at day 6 
for this experiment. The oxygraph was calibrated beforehand 
according to the manufacturer’s protocol. Following treatment, 
the cells were trypsinized and counted. Then 1x106 cells were 
transferred into the oxygraph respiration chamber containing 
Hedly’s intracellular buffer. Saponin (1μM) (Sigma, 47036) was 
added to the cells to permeate them where after, mitochondrial 
complex I substrates, malate (5μM) (Sigma, M1000) and 
glutamate (10μM) (Sigma, G1251) and the mitochondrial com-
plex II substrate succinic acid (100μM) (Sigma, S3674) were 
added. Active respiration was induced by the addition of 
adenosine dinucleotide (ADP) (Sigma, 01905). Respiration rate 
was then measured for 60 mins. The average respiration rate 
during this period was determined and compared between 
groups. Carbonyl cyanide-p-trifluoro-methoxy-phenyl-hydra-
zone (FCCP) (Sigma, C2920), a mitochondrial un-coupler was 
used to confirm that mitochondria were actively respiring at the 
end of the experiment.
Statistical analysis
All data are presented as the mean ± SEM. Comparisons 
between the different groups were performed by one-way 
ANOVA followed by Bonferroni’s post hoc test conducted 
with the statistical programme GraphPad Prism, version 5.0 
(GraphPad Inc.). A value of p<0.05 was considered statistically 
significant.
Lab 2
Cell culture and general cell maintenance
The H9c2 (2-1) cell line purchased from ECACC through 
Sigma Aldrich was maintained in a proliferative state through 
culture in high (4.5g/L) glucose DMEM (Lonza, BE12-604F) 
supplemented with 10% FBS (Sigma, F6178) and 1% penicillin/
streptomycin (Sigma, P4333) at 37°C and 5% CO2, as described 
above. No attachment factor was necessary.
Growth medium of the cells was changed every 2 - 3 days and 
the cells were split in a ratio of 1:3 once they reached 70 - 80% 
confluency. Warm phosphate buffered saline (PBS) was used 
for all washing steps. A combination of trypsinization and cell 
scraping was used to lift cells from the base of the culture plates 
for the purpose of cell division, or collecting cells for Western 
blotting. Centrifugation at 700rpm for 4 mins at 4°C was used 
when pelleting of cells was necessary. Cells between passage 18 
and 25 were used for differentiation experiments.
Differentiation of H9c2 cells
Once the cells were 70 - 80% confluent, differentiation was 
initiated by switching to DMEM growth medium supplemented 
with either 1% FBS or 1% Horse Serum (HS) (Biochrome AG, 
S9135), as well as daily administration of RA (Sigma Aldrich, 
R2625). Several different concentrations of RA were tested 
(10nM, 30nM and 1μM). Initially distilled water (d.H2O) and 
phosphate buffered saline (PBS) were used for the serial-
dilution preparation of the RA, however, in subsequent pro-
tocol repeats, dimethylsulphoxide (DMSO) (Merck, 102931) 
was used as RA was found to be inadequately dissolved in the 
d.H2O and PBS. DMSO alone was therefore also used as a 
vehicle control. Cells were cultured under these conditions for 
a period of 8 - 12 days with growth medium changed every 
second day. Control cultures received DMEM growth medium 
supplemented with 10% FBS, and medium was also changed 
every 2 - 3 days. 
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Western Blot analysis for markers of cardiac differentiation
Following treatment, cell lysates were prepared using a bullet 
blender homogeniser (Next Advance Bullet Blender 24) and 
lysis buffer (200mM Tris+ EGTA, 10mM EDTA, 1M NaCl, 
1mM ß-glycerophosphate, 2.5mM tetra-Na-pirophosphate, 
10mM Na3VO4, 10μg/ml Leupeptin, 10μg/ml Aprotinin, 1% 
Triton x-100 and 50μg/ml PMSF). Protein determination was 
carried out using the Bradford method.(22) Following 5 mins of 
boiling, lysates were stored at -80°C in Laemmli sample buffer. 
Cardiac tissue samples were also prepared via pulverising and 
homogenising frozen heart tissue in a lysis buffer solution. 
These lysates were used as positive controls for cardiac specific 
markers.
Depending on the protein yield, between 15 - 18μg of protein 
was loaded per sample and resolved according to the molecular 
weight on an SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) system, using a 12% acrylamide gel. This was followed 
by transfer of the proteins to an inert polyvinyl fluoride (PVDF) 
membrane via a wet tank-transfer or semi-wet TurboBlot 
system. Protein samples were fixed onto the membrane and 
5% milk was used as a blocking agent to minimise non-specific 
binding of antibodies. The specific proteins of interest were 
selected by overnight incubation of membranes at 4°C with 
primary antibodies directed against cardiac specific markers, 
myosin-Light chain 2v (MLC2v) (Cell Signaling, 1297) and 
Cardiac Troponin T (cTnT) (Cell Signaling, 5593).(20) Membranes 
were then further incubated at room temperature with anti-
rabbit secondary antibody (Cell Signaling, 7074), and visualised 
using a chemiluminescence interaction between the detection 
reagent and the anti-rabbit horseradish peroxidase conjugated 
secondary antibody. Proteins were detected using either a 
Chemi-Doc system in association with stain-free technology,(23) 
or exposure in a traditional dark room. Stain-free technology 
was used to confirm equal loading (supplementary data).
This procedure was repeated 3 times with between 2 - 4 cell 
plates per condition (10nM RA, 30nM RA, 1μM RA, control, 
vehicle control and positive heart sample controls). 
RESULTS
Lab 1
Morphological assessment
Differentiation of H9c2 cells was induced through serum 
reduction and daily supplementation with RA for 11 days, as 
described above. Undifferentiated H9c2 cardiomyoblasts are 
typically mononucleated and spindle shaped,(9) whereas once 
differentiated, the cells have been reported to form long, thin, 
branched multinucleated cardiomyotubes.(20)
After 6 days of daily RA treatment and/or serum reduction, 
only very few cells had begun to display the anticipated 
cardiomyotube morphology. According to Yang and colleagues 
(2014), immature cardiomyocytes present themselves in a 
circular (rounded) shape while mature cells are rod (elongated) 
shaped.(24) When compared to control cells (Figure 1E), no 
obvious differences were observed between the serum starved 
group (Figure 1A) and the serum starved plus RA treatment 
group (Figure 1B). Differentiation treatment was continued and 
by day 11 more cells appeared to have undergone differentiation 
in both groups when compared to control (Figures 1C and 1D). 
These cells presented with elongation and shrunken width 
indicative of differentiation (supplementary Figures 1 and 2). 
Cardiac troponin T (cTnT) expression
Immunocytochemistry was used to assess the expression of 
cTnT indicative of differentiation. In addition, the number of 
nuclei per cell were also noted. Cells expressing cTnT, as well 
as presenting more than 2 nuclei, were regarded as differen-
tiated cardiomyotubes. Figure 2A indicates that after 6 days, 
serum reduction alone did not result in substantial cTnT 
expression. However, Figure 2B shows that the combination of 
serum reduction with RA supplementation did increase the 
expression of cTnT, when compared to control cells (Figure 
2E) after 6 days. By day 11, the expression of cTnT in the serum 
starved group (Figure 2C) had increased in comparison to day 
6 (Figure 2A), with more cardiomyotubes containing multiple 
nuclei. Similarly, the combination of serum reduction and RA 
resulted in a greater expression of cTnT after 11 days (Figure 
2D), and a greater capacity to induce the formation of 
multinucleated cardiomyotubes. Supplementary Figure 2 shows 
the morphology of these cells in conjunction with the fluores-
cent signal.
Myosin Light Chain 2V (MLC-2v) expression
The expression of a second cardiac specific marker, MLC, was 
investigated using Western blotting in an effort to further 
distinguish between myoblasts and differentiated cardio-
myotubes. MLC has been used as an indicator of myoblast 
differentiation into cardiomyotubes.(25)
Figure 3 shows that the combination of serum starvation with 
RA supplementation significantly increased the expression of 
the marker (209.5 ± 7.4%, p<0.001) when compared to the 
serum only (118.4 ± 9.9%) and control (100.0 ± 9.8%) group 
on day 6. A substantial increase in the expression of MLC was 
further observed in both the serum only (236.9 ± 16.6%, 
p<0.001) and combination group (244.4 ± 9.2%, p<0.001) 
compared to the control by day 11 of treatment. Large 
differences were also observed between the reduced serum 
groups on days 6 and 11. The results obtained here suggest that 
under conditions of reduced serum only, the expression of 
cardiac specific markers takes much longer than when serum 
reduction is combined with RA supplementation. However, it 
was also noted that RA appears to lose its effect on the 
expression of MLC when the treatment period is extended. 
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FIGURE 1: Morphological assessment of H9c2 differentiation, analysed using bright field microscopy on days 6 and 11. (n=3). 
A: 1% FBS after 6 days; B: 1% FBS plus RA at 6 days; C: 1% FBS at 11 days; D: 1% FBS plus RA at 11 days, and E: control (10% FBS). Arrows 
indicate possible cardiomyotube formation. Magnification = 5x. Scale bar = 0.1 mm.
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SUPPLEMENTARY FIGURE 1: Morphological assessment of H9c2 differentiation, analysed using bright field microscopy on 
days 6 and 11. (n=3). A: 1% FBS after 6 days; B: 1% FBS at 11 days; C: 1% FBS plus RA at 6 days; D: 1% FBS plus RA at 11 days, and E: control 
(10% FBS). Cell outlines indicate differences in morphology attributable to the degree of maturity or differentiation of the cells, where a round 
appearance is associated with immature cells, while the rod shaped cells are more mature. Magnification = 5x. Scale bar = 0.1 mm.
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FIGURE 2: Analysis of cardiac troponin T (cTnT) expression following H9c2 differentiation for days 6 and 11. (n=3). A: 1% FBS 
(6 days), B: 1% FBS plus RA (6 days), C: 1% FBS (11 days), D: 1% FBS plus RA (11 days) and E: control. Green: cardiac troponin expression. 
Blue: nuclei. Magnification = 20x. Scale bar = 0.05 mm.
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SUPPLEMENTARY FIGURE 2: Analysis of cardiac troponin T (cTnT) expression following H9c2 differentiation for days 6 
and 11. Cell outlines indicate the morphology of these cells. (n=3). A: 1% FBS (6 days), B: 1% FBS (11 days), C: 1% FBS plus RA 
(6 days), D: 1% FBS plus RA (11 days) and E: control. Green: cardiac troponin expression. Blue: nuclei. Yellow outline: immature cells. White 
outline: differentiated mature cells. Magnification = 20x. Scale bar = 0.05 mm.
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FIGURE 4: Oxygen respiration rate following differ-
entiation with result presented as mean ± SEM (n=4). 
***p<0.001 vs control. **p<0.001 vs 1% FBS.
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Oxidative phosphorylation analysis
The switch in preferential energy metabolism, from glycolysis 
to oxidative phosphorylation, is a fundamental characteristic 
observed in differentiated cardiac cells.(21) Thus determining the 
rate of oxygen respiration would provide an ideal measure of 
oxidative phosphorylation in differentiated H9c2 cells. It should 
be noted that this variable was only investigated in cells 
differentiated for 6 days and no fatty acids were included as the 
researchers merely aimed to establish if a change in oxygen 
consumption was evident following differentiation. A significant 
increase in respiration rate was observed in both serum starved, 
and serum starved plus RA groups versus the control (100.0 ± 
6.1nM O2/million cells), indicative of differentiation (Figure 4). 
Large differences were also observed between the reduced 
serum group (131.9 ± 5.2nM O2/million cells, p<0.05) 
compared to the serum starved plus RA group (230.7 ± 15.8nM 
O2/million cells, p<0.001).
From the above results it can be seen that serum starvation, 
combined with daily RA supplementation, presents a positive 
influence on cardiomyoblast differentiation and the expression 
of cardiac specific proteins. It was also evident that supple-
mentation with RA mediated the switch in substrate utilisation 
during differentiation to oxidative phosphorylation. Although a 
reduction in serum concentration was seen to produce similar 
characteristics, the effects were far less pronounced. This study, 
however, was not able to establish a definitively homogenous 
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FIGURE 3: Myosin light chain (MLC) protein expression 
following cardiomyoblast differentiation. 
A: Bar graph and B: Western blot representation of MLC 
expression. Result are presented as mean ± SEM (n=3). 
***p<0.001 vs control. *p<0.001, **p<0.01 vs 1% FBS (6 days). 
C: Western blot representation of GAPDH expression, 
illustrating equal protein loading. Quantification of this blot is 
also shown in supplementary Figure 3.
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SUPPLEMENTARY FIGURE 3: Bar graph illustrating 
equal protein loading of GAPDH for blots probed for 
MLC expression conducted by Lab 1. 
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cell population, and even though many cells did undergo 
differentiation, the majority seemed to remain undifferentiated 
as was evident from light microscopy. 
Lab 2
In this laboratory, cells were treated daily with RA (10nM, 30nM 
and 1μM) and reduced serum (1% FBS or HS), and cultured 
over a period of 8 - 12 days, followed by Western blot analysis 
probing for the cardiac specific markers cTnT and MLC-2v. 
Figure 5, however, clearly indicates that in our investigations no 
presence of either of these 2 cardiac markers was detected via 
Western blotting methods. The only visible bands appeared 
under the positive heart control samples, suggesting no fault 
with the primary or secondary antibodies used, or the blotting 
techniques, and rather indicating that no significant differentiation 
of the H9c2 cells had taken place.
This lack of meaningful differentiation was confirmed by initial 
light microscopy observations (supplementary Figure 5), which 
revealed a cell population similar to the undifferentiated cell 
type, with only a few cells showing changes in cell mor-
phology – echoing the results obtained in Lab 1.
DISCUSSION
The H9c2 cell line is a versatile cell line, which due to its cardiac 
origin, has been used extensively in cardiac research. The cells 
are, however, fundamentally undifferentiated myoblasts. It has 
previously been reported that culturing these cells over a 
period of days in relatively low concentrations of FBS, as well as 
in the presence of RA will stimulate differentiation into a more 
cardiac-like phenotype. We were, however, unable to elicit 
suitable differentiation as defined by attaining a relatively 
homogenous cell population. These results were obtained in 2 
laboratories working independently of each other, thereby 
confirming the resistance of these cells to differentiation.
Three different parameters were used to assess the level of 
differentiation, namely: metabolic profile, expression of cardiac 
FIGURE 5: Western blots probed for cardiac specific markers. A: Cardiac Troponin T and B: Myosin light chain 2v, following the 
differentiation protocol with RA and reduced serum. Bands are only visible for the 2 positive control heart tissue samples loaded. No 
cardiac markers were detected in either the undifferentiated control cells, or the cells that have undergone differentiation culturing. Equal 
protein loading is demonstrated through the corresponding Western blot transfer images above each blot. This data is also quantified and 
depicted in Supplementary Figure 4.
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SUPPLEMENTARY FIGURE 4: Bar graphs representing equal protein loading of Western blot transfers probed for cardiac 
specific markers. A: Cardiac Troponin T and B: Myosin light chain 2v, following the differentiation protocol with RA and reduced serum. 
Comparisons were done using either an unpaired T-test, or a one-way ANOVA  followed by Bonferroni’s post hoc test. Since the protein 
profile of the heart tissue control was visibly different than the protein profiles from the H9c2 cells, this group was not included in the 
statistical analysis.
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specific proteins and cell morphology. Concerning metabolic 
preference, it is known that heart tissue is predominantly 
dependent on oxidative phosphorylation, while the H9c2 
myoblasts are mostly dependent on glycolytic metabolism. 
Using the described differentiation protocol, Pereira and 
colleagues(20) demonstrated a shift from glycolytic metabolism 
to oxidative phosphorylation in the differentiated cells. We also 
observed such a shift in terms of an increased capacity for the 
differentiated cells to utilise oxygen. This was especially true for 
cells treated with RA. This observation confirms that although 
long-term culture in 1% FBS can induce differentiation,(9,18) the 
addition of RA is necessary to optimally drive the cells in the 
direction of cardiomyotubes.(20) Investigations into the expres-
sion of cardiac specific proteins, specifically cTnT and MCL, 
revealed a less robust degree of differentiation. Lab 1 showed 
an increase in the expression of both these proteins, again 
dependent on the inclusion of RA in the culturing media, while 
Lab 2 failed to demonstrate any expression of these proteins, 
despite testing several concentrations of RA, as well as com-
paring FBS with horse serum. Finally, cell morphology also 
indicated a less than optimal result, in that a relatively small 
proportion of the cell population exposed to the differentiation 
media demonstrated the expected morphology. As with the 
other measurements, the inclusion of RA was associated with a 
greater increase in the degree of the total cell population 
showing multi-nucleation.
It is interesting that Lab 1 found quite an impressive degree of 
differentiation in terms of protein expression and oxygen-
dependent metabolism, which was not necessarily reflected in 
the degree of morphological change. This could be due to 
differences in the stage of differentiation, where it could be 
argued that intracellular changes precede morphological differ-
entiation. Our criteria for the experimental use of differentiated 
H9c2 cells was that the cells should be homogenous and 
differentiation complete, as determined by several end-points. 
The fact that many of the cells did not have the morphology of 
mature heart cells therefore led to doubt concerning the exact 
nature of these cells and if they were completely differentiated. 
Although the use of several end-points is the optimal way to 
assess differentiation, it is a short-coming in the field that there 
are no consensus characteristics and criteria to define differ-
entiated H9c2 cells. This lack could impede effective compari-
son and replication in science.
In summary, our combined results indicate that incubation of 
H9c2 cells for between 6 - 12 days with 1% FBS and 10nM RA 
does stimulate differentiation of the cells into a more cardiac-
like cell, although this only occurs in a portion of the cells. The 
protocol is therefore unsuccessful in stimulating robust differ-
entiation capable of generating a homogenous cell population. 
This therefore limits the potential utilisation of this approach for 
general research purposes. Potential reasons for the discrepancy 
between our laboratories and the work published by Menard, 
et al.(19) and Pereira, et al. (20) are unknown. Two potential con-
founding variables must be kept in mind, namely (i) the passage 
number and history of the cells used in the differentiation 
experiments and (ii) the handling of RA. 
SUPPLEMENTARY FIGURE 5: Representative images of the morphological changes occurring with differentiation in 
Laboratory 2. A: H9c2 control cells (10% FBS) compared to B: cells exposed to treatment with 1µM RA and reduced serum (1% FBS) for a 
period of 12 days. Some of the cells exposed to treatment showed some signs of morphological change but overall, little differentiation was 
visible. A Nikon Eclipse TE2000-S Laser Dissection and Fluorescence microscope was used. Magnification = 10x. Scale bar = 100µm.
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Concerning the passage number, there does not seem to be 
consensus regarding the optimal passage number for experi-
menting with H9c2 cells and, in fact, information concerning the 
effects of aging cell culture on the cells seems sparse. Recently, 
Witek and colleagues reported that passage number influences 
the response of H9c2 cells to cytotoxic agents.(26) In the con-
text of differentiation, passage number is an unknown, but 
probably relevant, variable. 
Regarding the handling of RA there are 2 important factors to 
consider: (i) RA is light sensitive and (ii) it is also extremely 
hydrophobic. The combination of these make it virtually impos-
sible to be absolutely confident that enough RA is truly dissolved 
in the growth medium to interact with the H9c2 cells. It has 
been reported that RA is stable under standard cell culturing 
conditions and, at least in the context of stem cells, is readily 
taken up by cells in culture(27-29) with a half-life ranging between 
3.5(30) and 6(31) hours, although 24 hours seems to be an accept-
able interval for the replenishment of RA. Both Tsukuda, et al. 
and Sharrow, et al. reported on the necessity of working with 
RA in the dark, or under yellow light illumination.(28,29) We took 
great care to protect the RA from light, while also dissolving it 
in sequential dilutions of DMSO before adding it to an aqueous 
medium. The dynamics of RA uptake in H9c2 cells is however 
unknown. This is a shortcoming in the existing literature on the 
use of RA to mediate the differentiation of H9c2 cells.
Despite our negative results, the benefit of differentiating the 
H9c2 cells into a more cardiac-like cell type is without doubt. 
Potential alternative variations on the current protocol include 
investigating the addition of other growth factors, in addition to 
RA, in order to drive a more robust differentiation, or finding 
alternative ways to effectively administer RA. These could 
include the generation of micelles, or the use of nanoparticles 
to ensure effective delivery of RA to the cells, or even just the 
inclusion of albumin in the growth medium in order to stabilise 
the RA.(28) A third variable to investigate is the time allowed for 
differentiation. Although both Menard, et al.(19) and Pereira, 
et al.(20) cultured their cells for 5 - 7 days, it is noteworthy that 
for the original description of the H9c2 cells by Kimes and 
Brandt(9) cells started showing pronounced myotube formation 
after 15 days of culturing and much less so after 7 days. It is 
therefore conceivable that an extended period of culturing, in 
the range of 15 - 20 days, might produce a more pronounced 
degree of differentiation. Yet a fourth variable, which has 
received some attention, is the surface on which the cells are 
cultured and differentiated. In this regard it has been reported 
that the degree of differentiation is influenced by interventions 
such as growing cells on an extracellular matrix(32) or growing 
cells on a surface with micro grooves.(33)
The most significant limitation of this study is that it was done 
in a retrospective manner, in other words the research efforts 
of the 2 laboratories were not planned or coordinated in 
advance. Effective collaboration would have entailed measuring 
the same end-points, making use of the same protocols and 
exchanging cells between laboratories at different points in the 
protocol. This limitation is however also a strength, since 
despite the absence of collaboration, we still reached similar 
conclusions.
In conclusion, long-term culture of H9c2 cells with 1% FBS and 
RA could induce a degree of differentiation, although this 
seemed limited to certain cells. The absence of a homogenous 
differentiated cell population, however, complicates the use of 
these cells for research. Investigators thus need to be aware of 
this when selecting this as an experimental model for their 
research.
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